EUVIMEDEUVIMED entdecken
Open Access

Nicotine Delivery of a Menthol-Flavored Heat-not-Burn Tobacco Product During Directed Use

Jessica M Yingst iD, Candace Bordner, Shari Hrabovsky, Andrea L Hobkirk iD, Neil Trushin, John P Richie, Jonathan Foulds iD

Nicotine and Tobacco Research · 2024

DOI: 10.1093/ntr/ntad119 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nicotine and Tobacco Research, 2024. Verfasst von Jessica M Yingst und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Public Health Sciences, Penn State College of Medicine, Hershey, PA, USA. Hauptthemen laut MEDLINE: Tobacco Products, Electronic Nicotine Delivery Systems. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDA NIH HHS, NCATS NIH HHS, NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

IQOS was authorized by the U.S. Food and Drug Administration (FDA) as a modified-risk tobacco product. We conducted a pharmacokinetic study evaluating the nicotine delivery and subjective effects of IQOS use among current menthol cigarette smokers to better understand if IQOS is an acceptable cigarette alternative in light of the proposed menthol cigarette ban. Aims and Methods Participants were adult smokers of >4 menthol cigarettes per day. After 14-hour nicotine abstinence, participants were provided an IQOS device and menthol heatstick to puff every 20 seconds for a total of 14 puffs. Blood samples were collected at baseline and during active use to calculate nicotine boost from baseline to peak concentration. Nicotine withdrawal symptoms were collected before and after IQOS use. In addition, a modified Product Evaluation Scale for IQOS was collected after use.

Results

Participants (n = 8) were a mean age of 43.9 years, 63% were female, 88% identified as White, and they smoked a mean of 17.1 menthol cigarettes per day. After IQOS use, the mean nicotine boost obtained was 15.96 ng/mL (SD = 6.91) (range 9.31 to 30.55 ng/mL). Most (75%) participants reported enjoying use of the product “a lot” or greater and more than half (62.5%) reported reduced cigarette cravings. Most participants reported no side effects after use; however, two experienced dry mouth, three experienced dizziness, one experienced throat irritation, and one experienced headache.

Conclusion

We found that directed use (14 puffs) of menthol IQOS delivered a mean nicotine boost of 15.96 ng/mL which reduced craving for a cigarette. The majority of participants enjoyed use of IQOS and reported mild side effects.

Implications

Menthol IQOS delivered a sufficient dose of nicotine perceived as satisfying by menthol cigarette smokers and it reduced craving with mild side effects. Menthol IQOS has potential to serve as a less harmful alternative for menthol cigarette smokers. The availability of modified risk products like IQOS should be considered by FDA’s Comprehensive Plan for Tobacco and Nicotine Regulation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tobacco ProductsElectronic Nicotine Delivery SystemsAdultFemaleHumansMaleNicotineMentholHot Temperature

Substanzen

NicotineMenthol

Autor:innen und Institutionen

  • Department of Public Health Sciences, Penn State College of Medicine, Hershey, PA, USA.
  • Penn State University College of Nursing, University Park, PA, USA.
  • Department of Psychiatry and Behavioral Health, Penn State College of Medicine, Hershey, PA, USA.

ORCID-Profile: Jessica M Yingst, Andrea L Hobkirk, Jonathan Foulds

Förderung

  • NIDA NIH HHS
  • NCATS NIH HHS
  • NIH HHS
  • Penn State Clinical & Translational Science Institute, Pennsylvania State University
  • NIH/NCATS
  • NIH

Zitieren

APA

Yingst, J. M., Bordner, C., Hrabovsky, S., Hobkirk, A. L., Trushin, N., Richie, J. P., & Foulds, J. (2024). Nicotine Delivery of a Menthol-Flavored Heat-not-Burn Tobacco Product During Directed Use. Nicotine and Tobacco Research. https://doi.org/10.1093/ntr/ntad119

Vancouver

Yingst JM, Bordner C, Hrabovsky S, Hobkirk AL, Trushin N, Richie JP, et al. Nicotine Delivery of a Menthol-Flavored Heat-not-Burn Tobacco Product During Directed Use. Nicotine and Tobacco Research. 2024. doi:10.1093/ntr/ntad119

BibTeX
@article{Yingst2024,
  author = {Yingst, Jessica M and Bordner, Candace and Hrabovsky, Shari and Hobkirk, Andrea L and Trushin, Neil and Richie, John P and Foulds, Jonathan},
  title = {Nicotine Delivery of a Menthol-Flavored Heat-not-Burn Tobacco Product During Directed Use},
  journal = {Nicotine and Tobacco Research},
  year = {2024},
  doi = {10.1093/ntr/ntad119}
}
Kostenlos starten →